All stock lists
Maravai Lifesciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
Healthcare · Biotechnology
7.57+0.24 (+3.35%)
Insider Score
––Not scored
MRVI Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
MRVI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 51.44 M | 65.84 M | 49.87 M | 41.63 M | 47.40 M | 46.85 M |
| Revenue Growth (YoY) | 8.53 % | 40.53 % | -11.59 % | -36.15 % | -35.43 % | -27.00 % |
| Cost of Revenue | 30.79 M | 32.14 M | 37.62 M | 35.98 M | 39.63 M | 39.13 M |
| Gross Profit | 20.65 M | 33.70 M | 12.24 M | 5.66 M | 7.77 M | 7.72 M |
| SG&A Expense | 32.07 M | 27.34 M | 15.19 M | 78.14 M | 38.58 M | 39.56 M |
| R&D Expense | 3.70 M | 3.89 M | 3.79 M | 9.77 M | 4.88 M | 4.89 M |
| Operating Expenses | 35.74 M | 31.23 M | 18.98 M | -109.78 M | 74.05 M | 56.89 M |
| Operating Income | -15.09 M | 2.47 M | -6.74 M | 115.44 M | -66.28 M | -49.16 M |
| Pretax Income | -21.80 M | -6.53 M | -63.01 M | -45.15 M | -74.13 M | -52.69 M |
| Tax Provision | -171.00 K | -151.00 K | 6.00 K | -92.00 K | -4.29 M | 162.00 K |
| Net Income | -12.42 M | -3.73 M | -35.68 M | -25.56 M | -39.59 M | -29.95 M |
| EPS (Basic) | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 |
| EPS (Diluted) | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 |
| Shares Outstanding | 148.00 M | 146.43 M | 145.07 M | 144.68 M | 144.24 M | 143.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
